Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
TERMINATED
NA
54 participants
INTERVENTIONAL
2014-09-30
2015-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Robotics Plus VR in Improving Cognition
NCT03914313
Trial to Evaluate the Effectiveness of Memory Training Workshops in People From 65 to 80 Years
NCT02431182
Computer-based Cognitive Rehabilitation Program for Healthy Older Adults, Older People With Mild Cognitive Impairment and Mild Dementia
NCT03430401
Telerehabilitation in Mild Cognitive Impairment
NCT03486704
Cognitive Remediation to Improve Mobility in Sedentary Seniors
NCT02567227
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Neurocognitive Rehabilitation
Rehabilitative approach based on exercises proposed as sensory-motor problems, whose solution involves the use of higher cognitive functions (attention, memory, language).
Neurocognitive Rehabilitation
The patients will be treated in inpatient clinic with a neurocognitive rehabilitation approach. The frequency will be two times a day for six days a week for four consecutive weeks. Followed by outpatient treatment three times a week for four weeks. Each session lasts about one hour.
Traditional Rehabilitation
It is a rehabilitative approach based on exercises for the recovery of hip's range of motion, muscle strengthening exercises, stretching exercises of the hamstring muscles, adductor and iliopsoas and proprioceptive exercises.
Traditional Rehabilitation
The patients will be treated in inpatient clinic with a traditional rehabilitation approach. The frequency will be two times a day for six days a week for four consecutive weeks. Followed by outpatient treatment three times a week for four weeks. Each session lasts about one hour.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Neurocognitive Rehabilitation
The patients will be treated in inpatient clinic with a neurocognitive rehabilitation approach. The frequency will be two times a day for six days a week for four consecutive weeks. Followed by outpatient treatment three times a week for four weeks. Each session lasts about one hour.
Traditional Rehabilitation
The patients will be treated in inpatient clinic with a traditional rehabilitation approach. The frequency will be two times a day for six days a week for four consecutive weeks. Followed by outpatient treatment three times a week for four weeks. Each session lasts about one hour.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* Concomitant osteoarthrosis of the hip or knee with gait restrictions
* Lameness for more than six months
* Central nervous system or Peripheral nervous system disorders
* Systemic inflammatory disorders (eg. Rheumatoid Arthritis)
* Systemic infectious disorders
* Cognitive impairment
* Neoplastic disorders
* Surgical revisions
* Intraoperative complications
* Suspected hip replacement infection
* Hip replacement with endoprosthesis.
50 Years
80 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Roma La Sapienza
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Teresa Paolucci
medical director
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Vincenzo Maria Saraceni
Role: PRINCIPAL_INVESTIGATOR
Umberto I Hospital, Sapienza University of Rome
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Umberto I Hospital
Rome, , Italy
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
3298/2014
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.